Ani Pharmaceuticals (ANIP) Buildings (2012 - 2013)

Ani Pharmaceuticals has disclosed Buildings across 2 years of filings, most recently posting $3.7 million for Q3 2013.

• In Q3 2013, Buildings changed N/A year-over-year to $3.7 million; the TTM figure through Sep 2013 stood at $3.7 million (changed N/A YoY), while the FY2012 annual figure was $3.7 million, changed N/A from the prior year.
• Buildings came in at $3.7 million for Q3 2013 at Ani Pharmaceuticals, roughly flat from $3.7 million in the prior quarter.
• In the past five years, Buildings ranged from a high of $3.7 million in Q4 2012 to a low of $3.7 million in Q4 2012.